During the past decade, Fundacion Hospital de Alcorcon; Servicio de Digestivo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fundacion Hospital de Alcorcon; Servicio de Digestivo" are "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "Fundacion Hospital de Alcorcon; Servicio de Digestivo" in a lesser frequency.

Most popular intervention types in "Fundacion Hospital de Alcorcon; Servicio de Digestivo" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Etrozulimab" (1 trials), "Infliximab" (1 trials), "Placebo" (1 trials) and "Placebo (IV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Hospital de Alcorcon; Servicio de Digestivo" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Hospital de Alcorcon; Servicio de Digestivo". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fundacion Hospital de Alcorcon; Servicio de Digestivo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Hospital de Alcorcon; Servicio de Digestivo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".